Astrazeneca (AZN)

 

Latest News

AZN's ZS-9 receives positive feedback

AstraZeneca (AZN) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

CHMP positive opinion for ZS-9 in hyperkalaemia

RNS Number: 8210X AstraZeneca PLC 24 February 2017 This announcement contains inside information 24 February 2017 12:30 GMT ZS-9 (sodium zirconium cyclosilicate) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HYPERKALAEMIA AstraZeneca today announced that the Committee for Medicinal Products for Human Use (CHMP)...

Broker Forecast - Berenberg issues a broker note on AstraZeneca PLC

Berenberg today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 5450p (fr...

AZ licenses Zoladex to TerSera for the US & Canada

RNS Number: 2530X AstraZeneca PLC 20 February 2017 This announcement contains inside information 20 February 2017 07:00GMT ASTRAZENECA ENTERS AGREEMENT WITH TERSERA THERAPEUTICS FOR ZOLADEX IN THE US AND CANADA AstraZeneca to receive upfront payment and sustainable and ongoing sales-based income Agreement e...

All News

DateHeadlineSource
24-02-17AZN's ZS-9 receives positive feedbackStockMarketWire
24-02-17CHMP positive opinion for ZS-9 in hyperkalaemiaRNS
22-02-17Broker Forecast - Berenberg issues a broker note on AstraZeneca PLCStockMarketWire
20-02-17AZ licenses Zoladex to TerSera for the US & CanadaRNS
17-02-17Unilever pushes FTSE higher on takeover approach by Kraft HeinzStockMarketWire
17-02-17Sterling weakens as slow spending threatens UK retail salesStockMarketWire
17-02-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
17-02-17FTSE 100 down an ace on lenders, minersStockMarketWire
17-02-17AZ reports positive results for Lynparza in cancer trial StockMarketWire
17-02-17Lynparza positive in metastatic BRCA breast cancerRNS
16-02-17Trump-Russia links concern investors StockMarketWire
16-02-17Neil Woodford’s seven trades in JanuaryInteractive Investor
16-02-17SILIQ (BRODALUMAB) APPROVED BY US FDARNS
13-02-17Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLCStockMarketWire
10-02-17Broker Forecast - Cantor Fitzgerald issues a broker note on AstraZeneca PLCStockMarketWire
07-02-17Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
07-02-17Broker Forecast - HSBC issues a broker note on AstraZeneca PLCStockMarketWire
06-02-17Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLCStockMarketWire
06-02-17Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
02-02-17Pound weakens as saving rate falls to 4%StockMarketWire
02-02-17These five blue-chip results cause ripplesInteractive Investor
02-02-17Broker Forecast - Cantor Fitzgerald issues a broker note on AstraZeneca PLCStockMarketWire
02-02-17Pound strengthens after MPs support Brexit billStockMarketWire
02-02-17AstraZeneca revenues fallStockMarketWire
02-02-17AZN: FY16 and Q4 2016 ResultsRNS
01-02-17Total Voting RightsRNS
01-02-17The stockmarket in February: Three winning stocksInteractive Investor
30-01-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
26-01-17Here's why FTSE 100 is in the blueInteractive Investor
26-01-17SYMBICORT GRANTED PAEDIATRIC EXCLUSIVITY IN THE USRNS
24-01-17Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLCStockMarketWire
23-01-17Broker Forecast - Investec issues a broker note on AstraZeneca PLCStockMarketWire
18-01-17Neil Woodford reveals latest tradesInteractive Investor
17-01-17AZ expands lung cancer programme StockMarketWire
17-01-17AZ 1st-line lung cancer immuno-oncology programmeRNS
04-01-17Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
03-01-17Total Voting RightsRNS
03-01-17Chart of the week: New target for this stockInteractive Investor
23-12-16FTSE 100 flat as HSBC dragsStockMarketWire
23-12-16AstraZeneca completes sale of certain rights to Pfizer StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory